著者: HuguesF C, MatteJ C, Le JeunneC, SalemA

原題: Effects of beta-adrenoceptors blocking eye drops in patients with chronic bronchitis.

著者: DuchS, DuchC, PastóL, FerrerP

原題: Changes in depressive status associated with topical beta-blockers.

著者: LipworthB J, IrvineN A, McDevittD G

原題: The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

著者: BauerK, Brunner-FerberF, DistlerathL M, LippaE A, BinkowitzB, TillP, KaikG

原題: Assessment of systemic effects of different ophthalmic beta-blockers in healthy volunteers.

著者: Le JeunneC, MuneraY, HuguesF C

原題: Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.

著者: BrooksA M, BurdenJ G, GilliesW E

原題: The significance of reactions to betaxolol reported by patients.

著者: BrügmannU, BlasiniR

原題: [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].

著者: HerpinD, BoutaudP, CiberM A, AmielA, DemangeJ

原題: [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].

著者: StewartR H, KimbroughR L, WardR L

原題: Betaxolol vs timolol. A six-month double-blind comparison.

著者: GiudicelliJ F, ChauvinM, ThuillezC, RicherC, BianchettiG, GomeniR, MorselliP L

原題: Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.

著者: BalnaveK, NeillJ D, RussellC J, HarronD W, LeaheyW J, WilsonR, ShanksR G

原題: Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.

著者: BerryD P, Van BuskirkE M, ShieldsM B

原題: Betaxolol and timolol. A comparison of efficacy and side effects.

著者: Vainio-JylhäE, VuoriM L

原題: The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.

著者: BöhlerS, SaubaduS, ScheldewaertR, FigullaH R

原題: Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.

著者: WaycasterCurtis R, GilliganAdrienne M, MotleyTravis A

原題: Cost-Effectiveness of Becaplermin Gel on Diabetic Foot Ulcer HealingChanges in Wound Surface Area.

著者: Martí-CarvajalArturo J, GluudChristian, NicolaSusana, Simancas-RacinesDaniel, ReveizLudovic, OlivaPatricio, Cedeño-TabordaJorge

原題: Growth factors for treating diabetic foot ulcers.

著者: ParkShin Ae, RaghunathanVijay Krishna, ShahNihar M, TeixeiraLeandro, MottaMonica J, CovertJill, DubielzigRichard, SchurrMichael, IsseroffRoslyn Rivkah, AbbottNicholas L, McAnultyJonathan, MurphyChristopher J

原題: PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds.

著者: TravisTaryn E, MauskarNeil A, MinoMatthew J, PrindezeNick, MoffattLauren T, FidlerPhilip E, JordanMarion H, ShuppJeffrey W

原題: Commercially available topical platelet-derived growth factor as a novel agent to accelerate burn-related wound healing.

著者: GowdaSantosh, WeinsteinDavid A, BlalockTimothy D, GandhiKavita, MastBruce A, ChinGloria, SchultzGregory S

原題: Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response.

著者: ChengChieh-Fang, SahuDivya, TsenFred, ZhaoZhengwei, FanJianhua, KimRosie, WangXinyi, O'BrienKathryn, LiYong, KuangYuting, ChenMei, WoodleyDavid T, LiWei

原題: A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice.

著者: ZiyadehNajat, FifeDaniel, WalkerAlexander M, WilkinsonGregg S, SeegerJohn D

原題: A matched cohort study of the risk of cancer in users of becaplermin.

著者: KirsnerRobert S, WarrinerRobert, MichelaMichelle, StasikLaure, FreemanKatherine

原題: Advanced biological therapies for diabetic foot ulcers.

著者: LandsmanAdam, AgnewPatrick, ParishLawrence, JosephRobert, GalianoRobert D

原題: Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis.

著者: MulderGerit, TallisArthur J, MarshallV Tracy, MozingoDavid, PhillipsLaurie, PierceGlenn F, ChandlerLois A, SosnowskiBarbara K

原題: Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial.

著者: SteedDavid L

原題: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.

著者: PerssonU, WillisM, OdegaardK, ApelqvistJ

原題: The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.

著者: SenetP

原題: [Becaplermin gel (Regranex gel)].